This inventor holds 2 USPTO granted patents. Top assignee: Columbia University. Active years: 1994-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1995
Title: Innovations of Nicholas A. Cacalano
Introduction
Nicholas A. Cacalano is a notable inventor based in Irvington, NY (US). He has made significant contributions to the field of immunology through his innovative research and inventions. With a total of 2 patents, Cacalano's work focuses on the development of derivatives of cyclosporine A and their applications.
Latest Patents
Cacalano's latest patents include groundbreaking inventions related to cyclosporine A. One of his notable inventions provides a molecule comprising cyclosporine A or a congener of cyclosporine A that is photochemically attached to a ligand containing a reactive group. This invention also includes a composition of matter that comprises a conjugate of a compound and the aforementioned molecule, wherein the compound is bound to the molecule through the reactive group. Furthermore, it provides an antibody directed to the composition of matter specific for cyclosporine A or its congeners. Additionally, Cacalano's inventions offer methods for monitoring levels of cyclosporine A in a subject, as well as methods for detecting its presence and concentration.
Career Highlights
Cacalano is affiliated with Columbia University, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in immunosuppressive therapies and the detection of immunoregulatory substances.
Collaborations
Cacalano has collaborated with esteemed colleagues such as Bernard F. Erlanger and William L. Cleveland, contributing to a rich environment of innovation and research.
Conclusion
Nicholas A. Cacalano's contributions to the field of immunology through his patents and research at Columbia University highlight his role as a significant inventor. His work on cyclosporine A derivatives showcases the potential for advancements in immunosuppressive therapies and monitoring techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
